期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy 被引量:6
1
作者 Yanan Li Cangang Zhang +4 位作者 Guo Li Guowei Deng Hui Zhang Yongbing Sun Feifei An 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第8期2220-2242,共23页
Proteases have a fundamental role in maintaining physiological homeostasis,but their dysregulation results in severe activity imbalance and pathological conditions,including cancer onset,progression,invasion,and metas... Proteases have a fundamental role in maintaining physiological homeostasis,but their dysregulation results in severe activity imbalance and pathological conditions,including cancer onset,progression,invasion,and metastasis.This striking importance plus superior biological recognition and catalytic performance of proteases,combining with the excellent physicochemical characteristics of nanomaterials,results in enzyme-activated nano-drug delivery systems(nanoDDS)that perform theranostic functions in highly specific response to the tumor phenotype stimulus.In the tutorial review,the key advances of protease-responsive nanoDDS in the specific diagnosis and targeted treatment for malignancies are emphatically classified according to the effector biomolecule types,on the premise of summarizing the structure and function of each protease.Subsequently,the incomplete matching and recognition between enzyme and substrate,structural design complexity,volume production,and toxicological issues related to the nanocomposites are highlighted to clarify the direction of efforts in nanotheranostics.This will facilitate the promotion of nanotechnology in the management of malignant tumors. 展开更多
关键词 protease-responsive Drug delivery NANOMEDICINE Multifunctional construction Precise diagnosis Targeted therapy Synergistic theranostic MALIGNANCY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部